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Background: Smoking increases the risk of hospitalization for pneumonia, yet it is unknown if
smoking cessation changes this risk. We sought to determine if smoking cessation and the dura-
tion of abstinence from tobacco reduce the risk of pneumonia hospitalization.
Methods: We performed secondary analysis of data collected from male United States
Veterans participating in a randomized trial. We used Cox proportional-hazard models to esti-
mate risk of hospitalization for pneumonia within one year of enrollment. We adjusted for
confounders, including: demographics, comorbidity, alcohol use, prior pneumonia, inhaled
corticosteroid use, and intensity of tobacco exposure. Among a restricted cohort excluding
never smokers, we assessed for effect modification by a diagnosis of chronic obstructive
pulmonary disease (COPD).
Results: Of the 25,235 participants, we identified 6720 current, 13,625 former, and 4890 never
smokers. Compared to current smokers, never smokers had a decreased (adjusted HR 0.48, 95%
CI 0.31e0.74), while former smokers had no difference in (adjusted HR 0.83, 95% CI 0.63e1.09)
risk of hospitalization for pneumonia. Among participants without COPD, former smokers had
a lower risk of hospitalization (adjusted HR 0.65, 95% CI 0.45e0.95). However, this lower riskre Quality Improvement Project; ACSC, Ambulatory care sensitive condition; AUDIT-C, Alcohol Use
tion; COPD, Chronic obstructive pulmonary disease; CHF, Congestive heart failure; CI, Confidence
nt; DM, Diabetes mellitus; GIMC, General internal medicine clinics; HR, Hazard ratio; ICD-9, Inter-
Edition; ICS, Inhaled corticosteroids; MI, Myocardial infarction; VA, Department of Veterans Affairs.
ices Research and Development, VA Puget Sound Health Care System, 1100 Olive Way, Suite 1400,
277 4191; fax: þ1 206 768 5343.
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1056 L.M. Cecere et al.was isolated to those who quit tobacco more than 10 years previously (adjusted HR 0.62, 95% CI
0.41e0.93). Among those with COPD, there was no difference in risk with smoking cessation or
duration of remaining tobacco-free.
Conclusions: Tobacco cessation is likely important in reducing hospital admissions for pneu-
monia, but its benefit depends on duration of smoking cessation and is likely attenuated in
the presence of COPD.
Published by Elsevier Ltd.Introduction
In the United States, pneumonia is responsible for more
than 1 million hospitalizations each year, resulting in
annual healthcare costs of more than 10 billion dollars.1
Despite its designation as an ambulatory care sensitive
condition (ACSC),2 or one for which hospitalization is
potentially preventable, rates of admission for bacterial
pneumonia have increased over time, particularly among
older adults.3,4
Efforts to date to reduce hospital admissions for pneu-
monia have concentrated largely on early diagnosis and
appropriate outpatient treatment, as well as primary
prevention with the use of the influenza and 23-valent
pneumococcal vaccines in at-risk populations.5 Despite the
efficacy of these vaccines in preventing influenza6 and
invasive pneumococcal disease,7,8 respectively, contro-
versy remains about their effectiveness against developing
severe pneumonia requiring hospitalization.9 Attempts to
eradicate preventable conditions known to increase the risk
of pneumonia and pneumonia-related hospitalizations,
such as chronic obstructive pulmonary disease (COPD),10e17
may be important in decreasing the burden of illness due to
pneumonia in the future.3
Smoking is the leading cause of COPD,18 and is itself
a strong predictor of pneumonia,10,11,16,19 need for
hospitalization12,13,15 and resulting mortality.14,20,21 While
a few studies suggest that smoking cessation may be
associated with a lower risk of developing pneumonia19,22
no study has examined its effect on rates of hospitaliza-
tion for the condition. We sought to determine if smoking
cessation and the duration of abstinence of tobacco were
associated with a lower risk of hospitalization for bacterial
pneumonia among a large cohort of United States
Veterans. Due to the strong association between COPD and
poor clinical outcomes among patients with pneumo-
nia,12e15,23,24 we also assessed whether or not this risk was
modified by a self-reported history of a physician diagnosis
of COPD.Methods
Study setting and population
We performed secondary analysis of data collected for the
Ambulatory Care Quality Improvement Project (ACQUIP),
a multi-center randomized trial to improve patient health
and satisfaction. The study population, methods and results
of this study have been described previously in detail.25Briefly, participants in ACQUIP received care at one of
seven Department of Veterans Affairs (VA) general internal
medicine clinics (GIMC) across the United States. Eligible
patients were required to have a valid mailing address, be
assigned a primary care provider, and have been seen at
least once in the past year with a follow-up visit scheduled.
For this analysis, we included all male patients enrolled in
ACQUIP between March 1997 and December 1998 who
returned the health inventory checklist described below
and had complete ascertainment of their alcohol use and
smoking status. The intervention consisted of collecting
information about targeted health conditions from patient
questionnaires, physiologic data from the medical record,
and ratings of patient health and satisfaction and then
providing this information to clinicians before each primary
care visit. This intervention had no effect on improving
patient health status or satisfaction with care,25 and we
included participants in both arms of the study in this
analysis. We excluded women because they made up only
5% of the study population. The human subjects commit-
tees at the University of Washington and all other partici-
pating sites approved the ACQUIP study protocol. The
Institutional Review Boards of the University of Washington
and VA Puget Sound approved the analyses presented here
(VA MIRB #01308).
Data collection
Participants in ACQUIP completed mailed surveys, including
a health inventory checklist containing questions about
chronic medical conditions and current and prior tobacco
exposure. Survey data were merged with hospital and
pharmacy records extracted from the VA electronic medical
record system and Medicare database. Collected data
included International Classification of Diseases 9th
Edition (ICD-9) diagnoses for all inpatient and outpatient
visits through December 1999 and all outpatient prescrip-
tions obtained from a VA facility. The date of enrollment, or
index date, was defined as the day the health inventory
checklist was processed.
Outcome and exposures of interest
Our primary outcome of interest for this study was risk of
first hospitalization for pneumonia occurring within one
year of enrollment. We identified all hospitalizations with
a primary ICD-9 discharge diagnosis of bacterial pneu-
monia as defined by the Agency for Healthcare Research
and Quality,2 including: 481, 482.2, 482.30, 482.31,
482.32, 482.39, 482.9, 483.0, 483.1, 483.8, 485, and 486.
Smoking cessation and pneumonia hospitalization 1057Using the health inventory checklist, we ascertained
whether patients were current, former or never smokers
as of the index date. Among those with a history of
tobacco use, we determined the average number of
cigarettes smoked daily in 10-cigarette increments up to
40 cigarettes per day. We grouped former smokers
based upon their self-reported time since quitting
smoking into the following categories: less than 1 year,
1e5 years, 6e10 years or more than 10 years since last
cigarette use.
Covariates
Using the survey data, we identified demographic infor-
mation for all participants as of the index date, including:
age, race, marital status and highest level of education. We
used the score on the self-reported Alcohol Use Disorders
Identification Test Consumption (AUDIT-C) questionnaire to
assess alcohol use and misuse, categorizing patients into
four groups: no past use (AUDIT-C score of 0), low-level use
(AUDIT-C score of 1e3), mild-moderate alcohol misuse
(AUDIT-C 4e7) and severe alcohol misuse (AUDIT-C
8e12).26e31 In addition, we identified the presence of seven
specific comorbid illnesses, including: prior myocardial
infarction (MI), diabetes mellitus (DM), history of cerebro-
vascular accident (CVA), congestive heart failure (CHF),
malignancy, COPD and prior pneumonia. Due to the
increased risk of pneumonia among users of inhaled corti-
costeroids (ICS),32 we identified participants receiving
a prescription for an ICS in the year prior to enrollment
using pharmacy data.
Statistical analysis
We utilized Cox proportional-hazard models to estimate the
risk of first hospitalization for pneumonia associated with
smoking status and length of smoking cessation.33 We fol-
lowed patients until their first hospitalization for pneu-
monia, and censored for death, end of follow-up, or at one
year post-enrollment. We assessed the relationship
between subsequent hospitalization for pneumonia and
both smoking status (entire cohort) and duration of absti-
nence from tobacco (including only those participants with
a history of tobacco exposure) after adjusting for all the
covariates listed above. In addition, we adjusted for the
average number of cigarettes smoked per day in the models
estimating associations of the time since quitting tobacco.
Lastly, we used stratified models to examine how the
relationship between smoking status and time since quit-
ting tobacco was modified by the presence or absence of
self-reported physician diagnosed COPD in a restricted
cohort including only former and current smokers. We
tested the proportional hazards assumption graphically and
via Schoenfeld residuals, and found it to be valid for all final
models, with the exception of the adjusted models
restricted to patients with COPD. In this case, the addition
of prior MI as a covariate caused a violation of the
proportional hazards assumption, and therefore it was
omitted from the final adjusted model. All statistical
analyses were performed using Stata-10 statistical software
(College Station, TX).Results
Study population
Of the 62,487 patients mailed the initial ACQUIP health
checklist questionnaires, 36,821 patients (59%) responded.
On average, these respondents were older (63 vs. 59 years)
and had a higher prevalence of comorbid conditions
including coronary artery disease, COPD, chronic heart
failure, depression, diabetes and hypertension. However,
after stratifying by age, the prevalence of these chronic
conditions among responders and non-responders was
similar. Of the 36,821 respondents, we identified 25,235
men (69%) who met eligibility criteria for this study. Of
these we identified 6720 (26.6%) current smokers, 13,625
(54.0%) former smokers, and 4890 (19.4%) never smokers.
Of the former smokers, the majority (n Z 8,760, 64.3%)
reported quitting more than 10 years prior to enrollment.
Current smokers were younger, more likely to be of black
race, less likely to be married, and less educated than
either former or never smokers (Table 1). Former smokers
were more likely to have had a previous MI or CVA, report
a history of prior pneumonia, be treated with an ICS, and
to carry a diagnosis of DM, CHF, or malignancy than either
current or never smokers. Former smokers were more
likely than never smokers, but less likely than current
smokers, to have a self-reported physician diagnosis of
COPD. However, when examined by duration of smoking
cessation, the proportion of former smokers who had quit
within the past five years who had a self-reported diag-
nosis of COPD was similar to that of current smokers. On
average, both former and current smokers reported
consuming about a pack per day of cigarettes. Current
smokers were more likely to report either mild-moderate
or severe alcohol misuse compared to former and never
smokers.Risk of hospitalization for pneumonia and smoking
status
During the year following enrollment, we identified 359
hospital admissions for pneumonia, occurring at a median
of 190 days (range 1e365 days). The overall incidence of
admissions for pneumonia among the cohort was 14.6 per
1000 person-years. Among former and never smokers, the
incidence of pneumonia was much higher among the 5074
participants with a self-reported diagnosis of COPD than
among the 15,266 subjects without such a diagnosis (32.6
hospitalizations per 1000 person/years vs. 10.8 hospitali-
zations per 1000 person/years, respectively).
In adjusted analyses and in comparison to current
smokers, never smokers were at decreased risk of hospi-
talization for pneumonia (Table 2). Former smokers had
a decreased point estimate of risk of hospitalization that
did not reach statistical significance. Similarly, among all
participants, we found no difference in risk of hospitali-
zation for pneumonia among former smokers with varying
lengths of abstinence from tobacco when compared to
current smokers (Table 2; p-value for linear
trend Z 0.07).
Table 1 Characteristics of participants by smoking status and duration of reported abstinence.
Current
smokers
Former smokers Never
smokersAll former
smokers
By duration of abstinence
Quit <1 yr Quit 1e5 yrs Quit 6e10 yrs Quit >10 yrs
N Z 6720 N Z 13,625 N Z 1053 N Z 1998 N Z 1814 N Z 8760 N Z 4890
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Age (years)a
<50 1950 (29) 1341 (10) 244 (23) 348 (17) 222 (12) 527 (6) 933 (19)
50e59 1814 (27) 2155 (16) 273 (26) 440 (22) 372 (21) 1070 (12) 812 (17)
60e69 1848 (28) 4471 (33) 334 (32) 690 (35) 653 (36) 2794 (32) 1253 (26)
70e79 997 (15) 4883 (36) 186 (18) 473 (24) 507 (28) 3717 (42) 1492 (30)
80 102 (1) 759 (5) 16 (1) 47 (2) 58 (3) 638 (7) 391 (8)
Racea
White 4691 (70) 10,380 (76) 719 (68) 1428 (71) 1351 (74) 6882 (79) 3355 (69)
Black 1544 (23) 1998 (15) 250 (24) 389 (19) 294 (16) 1065 (12) 947 (19)
Other 321 (5) 758 (6) 54 (5) 123 (6) 107 (6) 474 (5) 432 (9)
Married 2920 (43) 8579 (63) 520 (49) 1105 (55) 1110 (61) 5844 (67) 2775 (57)
Educationa
<High school 1912 (28) 4062 (30) 257 (24) 574 (29) 494 (27) 2737 (31) 1046 (21)
High school grad 4003 (60) 7314 (54) 644 (61) 1132 (57) 1061 (58) 4477 (51) 2557 (52)
College grad 670 (10) 1929 (14) 126 (12) 248 (12) 224 (12) 1331 (15) 1172 (24)
Comorbid illness
Previous MI 1156 (17) 2944 (22) 214 (20) 450 (23) 417 (23) 1863 (21) 634 (13)
Diabetes mellitus 1102 (16) 3303 (24) 189 (18) 438 (22) 441 (24) 2235 (26) 1092 (22)
Previous CVA 705 (10) 1546 (11) 111 (11) 261 (13) 199 (11) 975 (11) 441 (9)
CHF 465 (7) 1299 (10) 97 (9) 206 (10) 182 (10) 814 (9) 309 (6)
Malignancy 597 (9) 1820 (13) 110 (10) 265 (13) 231 (13) 1214 (14) 506 (10)
COPD 1935 (29) 3139 (23) 310 (29) 616 (31) 466 (26) 1747 (20) 574 (12)
Prior pneumonia 924 (14) 2006 (15) 165 (16) 308 (15) 255 (14) 1278 (15) 444 (9)
Use of ICS 495 (7) 1173 (9) 127 (12) 234 (12) 176 (10) 636 (7) 180 (4)
Cigarettes/day (Mean, SD) 18.9 (10.4) 20.6 (11.4) 20.7 (11.1) 21.4 (11.2) 22.3 (11.2) 20.1 (11.5) N/A
Alcohol use (AUDIT-C score)
No past use (0) 2501 (37) 6634 (49) 434 (41) 1008 (50) 877 (48) 4315 (49) 2488 (51)
Low-level use (1e3) 1808 (27) 4392 (32) 364 (35) 588 (29) 606 (33) 2834 (32) 1636 (33)
Mild-moderate misuse
(4e7)
1500 (22) 2128 (16) 185 (18) 314 (16) 272 (15) 1357 (15) 612 (13)
Severe misuse (8e12) 911 (14) 471 (3) 70 (7) 88 (4) 59 (3) 254 (3) 154 (3)
a Some column totals do not add to 100% due to missing values; Abbreviations: MI Z Myocardial infarction; CVA Z Cerebrovascular
accident; CHF Z Congestive heart failure; COPD Z chronic obstructive pulmonary disease; ICS Z Inhaled corticosteroid.
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of COPD
Among former and current smokers who did not endorse
having a physician diagnosis of COPD, we found a signifi-
cantly lower risk of hospitalization among former smokers
when compared to current tobacco users after adjustment
for age, demographics, alcohol use/misuse, non-pulmonary
comorbid illness, history of prior pneumonia, use of ICS,
and intensity of tobacco exposure (cigarettes/day) (Table
3). Furthermore, among former smokers, we found the
lower risk to be isolated to those who quit tobacco more
than 10 years previously. In contrast, among former and
current smokers with a self-reported physician diagnosis of
COPD, we found no difference in risk of hospitalization
dependent on smoking status or on time since quitting
tobacco when compared to current smokers (Table 3).Discussion
In a large cohort of more than 25,000 Veterans, we found
smoking cessation was an important predictor of the risk of
pneumonia, but that risk was dependent on the duration of
cessation as well as whether patients had recognized COPD.
These findings are important as they suggest that smoking
cessation could be beneficial in reducing future hospitali-
zations for pneumonia, but that in order to be effective,
quitting smoking likely needs to occur early in life.
Furthermore, these results suggests that as clinicians
discuss the importance of smoking cessation that they may
include the concept that benefits to lung health may be
most substantial prior to developing lung disease, such as
COPD.
To our knowledge, no previous study has assessed the
relationship between smoking cessation and hospitalization
Table 2 Risk of hospitalization for pneumonia by smoking status and duration of abstinence.
Tobacco exposure Total
(N )
Admissions
(N )
Person-years Rate (per 1000 person-years) Adjusted hazard
ratio (95% CI)
Smoking status
Current 6720 89 6557 13.6 1.00a
Former 13,625 232 13,241 17.5 0.83 (0.63e1.09)
Never 4890 38 4825 7.9 0.48 (0.31e0.74)
Duration of smoking cessation
Current 6720 89 6557 13.6 1.00b
Quit <1 year 1053 15 1020 14.7 0.93 (0.52e1.66)
Quit 1e5 years 1998 38 1938 19.6 0.95 (0.63e1.42)
Quit 6e10 years 1814 31 1763 17.6 0.79 (0.50e1.26)
Quit >10 years 8760 148 8520 17.4 0.77 (0.57e1.04)
Values in bold indicate p-value<0.05.
a Adjusted for age, race, marital status, education level, alcohol use, previous myocardial infarction, diabetes mellitus, history of
cerebrovascular accident, congestive heart failure, malignancy, prior pneumonia, use of ICS, and diagnosis of COPD.
b Adjusted for same demographics and comorbid illnesses, with additional adjustment made for cigarettes per day consumed (p-value
for linear trend Z 0.07).
Smoking cessation and pneumonia hospitalization 1059for pneumonia. However, two prior studies suggest
smoking cessation to be associated with a reduced risk of
developing pneumonia in the first place. In a population
based caseecontrol study, Almirall et al. found the odds of
developing pneumonia was reduced by 50% after 5 years of
smoking cessation.19 Similarly, Baik et al. found formerTable 3 Risk of hospitalization for pneumonia by smoking sta
physician diagnosis of chronic obstructive pulmonary disease (CO
Tobacco exposure Total
(N )
Admissions
(N )
Person
No self-reported diagnosis of COPDa
Smoking status
Current 4785 49 4694
Former 10,481 113 10,247
Duration of smoking cessation
Current 4785 49 4694
Quit <1 year 743 5 727
Quit 1e5 years 1381 14 1350
Quit 6e10 years 1347 16 1315
Quit >10 years 7010 78 6855
Self-reported diagnosis of COPDa
Smoking status
Current 1935 40 1863
Former 3139 118 2990
Duration of smoking cessation
Current 1935 40 1863
Quit <1 year 310 10 292
Quit 1e5 years 616 24 587
Quit 6e10 years 466 15 448
Quit >10 years 1747 69 1663
Values in bold indicate p-value <0.05.
a Adjusted for age, race, marital status, education level, alcohol u
cerebrovascular accident, congestive heart failure, malignancy, prior
b p-value for linear trend Z 0.03.
c Adjusted for same covariates listed above, with the exception of
violation of proportional hazard assumptions.
d p-value for linear trend Z 0.75.smokers who quit smoking less than ten years prior had
a 1.5 times higher risk, while those who had quit for ten or
more years had no difference in risk, of developing pneu-
monia when compared to never smokers.22 Based on these
studies, we expected to find a similar reduction in risk of
hospitalization for pneumonia among all former smokers,tus and duration of abstinence, stratified by self-reported
PD).
-years Rate (per 1000 person-years) Adjusted hazard
ratio (95% CI)
10.4 Referenta
11.0 0.65 (0.45, 0.95)
10.4 Referenta,b
6.9 0.64 (0.25, 1.64)
10.4 0.71 (0.38, 1.35)
12.2 0.77 (0.41, 1.47)
11.4 0.62 (0.41, 0.93)
21.5 Referentc
39.5 1.04 (0.70e1.54)
21.5 Referentc,d
34.2 1.24 (0.59e2.58)
40.9 1.23 (0.72e2.10)
33.5 0.83 (0.42e1.61)
41.5 0.99 (0.64e1.53)
se, previous myocardial infarction, diabetes mellitus, history of
pneumonia, use of ICS, and average cigarettes per day.
myocardial infarction, which was omitted from the model due to
1060 L.M. Cecere et al.however this was not the case. Our patient population has
a high prevalence of COPD, a finding that is consistent with
previous studies showing a higher occurrence of COPD
among United States Veterans than the general pop-
ulation.34 This is likely due primarily to high rates of
tobacco smoking within this group, but age, exposure to
passive tobacco smoke and occupational exposures are
also risk factors for COPD,34,35 which may help explain the
12% of never smokers with self-reported COPD in this
cohort. We hypothesize that differences between the
results of our study and those previously published could
be due to this high prevalence of COPD within our pop-
ulation, which will have driven our findings for our non-
stratified analyses toward the null. This is supported by
the fact that we did find a similar reduction to these other
studies in risk among former smokers without a self-
reported diagnosis of COPD.
There are several possible explanations for our finding
that ex-smokers without COPD have reduced risk of hospi-
talization for pneumonia compared to current smokers,
whereas among patients with self-reported COPD this
association is not observed. First, there are several biologic
mechanisms thought to result in increased susceptibility to
respiratory infection among smokers. These include
a number of alterations to the host immune system, ranging
from impaired ciliary function36 to depressed T-cell activity
and natural killer cell function.37,38 Although many of these
changes are likely reversible over time with smoking
cessation, the immune dysfunction that occurs with
smoking tobacco may be less reversible among patients
with COPD.39 Second, patients who are able to achieve
smoking cessation are also likely to achieve other healthy
behaviors, such as reducing alcohol intake and following up
with primary care physicians, which could result in earlier
diagnosis and treatment and a subsequent reduction in
their risk of hospitalization. COPD has been associated with
the development of pneumonia severe enough to result in
hospitalization,12e15 need for mechanical ventilation23 and
death,14,23,24 and smoking cessation alone, or in combina-
tion with other healthy behaviors, may not be sufficient to
reduce the incidence of hospitalization among this patient
group.
The majority of the estimated 1 in 5 adult tobacco users
in the United States40 began smoking at an early age,41 and
the incidence of tobacco use is higher among adolescents
than older adults.40 Patients who are young and have not
yet had undesirable health consequences from smoking
may be reluctant to attempt smoking cessation. There is
evidence that smoking cessation interventions that incor-
porate “gain-framed” messages, or highlight the benefits of
abstinence from tobacco, may be more successful than
those that are “loss-framed,” or emphasize the costs of
continued smoking.42,43 Our results suggest that clinicians
providing counseling about the benefits of smoking cessa-
tion can emphasize not only that smoking cessation reduces
the risk of common tobacco-related lung diseases, such as
COPD and lung cancer, but also educate patients about the
importance of quitting early in life, when other adverse
health outcomes, such as hospitalization for pneumonia,
may be still modifiable.
This study has some potential limitations. First, we
relied upon self-report to determine current smoking statusand the duration of abstinence among former smokers,
which could result in potential misclassification of exposure
status. Due to social desirability, participants may have
under-reported current tobacco use or over-estimated their
duration of abstinence, which could have resulted in
biasing the study toward the null. Second, we could not
account for the duration of tobacco exposure. However, as
most patients begin smoking at around the same time and
at a young age, adjustment for duration of use, in addition
to age and average intensity of tobacco exposure, would
likely not significantly change our findings. Third, we relied
upon self-report of a physician diagnosis, rather than
spirometry, to identify patients with COPD, which could
result in misclassification. However, the high prevalence of
COPD within our population is similar to that found in
previous studies of United States Veterans. Fourth, our
findings may not generalize to women, who are less likely to
be hospitalized, less likely to require intensive care
admission and to have a lower pneumonia-related mortality
than men.44 Lastly, although the intervention had no effect
on improving patient’s health status, and is therefore
unlikely to have an effect on our outcome of interest, our
study participants did tend to be older, white men, with
high rates of comorbid COPD, which could affect the
generalizability of our results.
This study had several strengths. First, we studied
patients from multiple centers minimizing the chance that
the patterns of diagnosis or treatment by any single
physician or group of clinicians exerted undue influence on
our results. Second, the cohort was drawn from
a complete primary care clinic population, reducing the
likelihood of selection bias, such as is often found in
randomized trials. Third, we had excellent reporting of
smoking status and the ability to follow patients continu-
ously in the VA system.
In conclusion, we found that smoking cessation is asso-
ciated with a reduction in the risk of hospitalization for
pneumonia, but only among patients without a diagnosis of
COPD, and then only among patients who quit smoking
more than 10 years previously. These findings give clinicians
additional important information to provide to patients
about the benefits of early smoking cessation and empha-
sizes the advantages of smoking cessation prior to the
development of lung disease.Funding source
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